Search

Salt Lake City-based Coherex Medical, a medical device firm developing treatments for heart defects, said today that it has raised $16.5M in a Series B funding round. The funding was co-led by vSpring Capital and Oxford Bioscience Partners, with Tullis Health Investors and an un-named, strategic investor also participating. The firm said the funding brings its total raised to $28.0M. Coherex has a device which repairs patent foramen ovale, a common heart defect.
posted on Thursday, August 20, 2009 (Link to more information)

Related companies:
Coherex Medical

Related stories:
> Coherex Medical Raises $8.5M in Funding
> Coherex Medical Acquired By Biosense Webster
> Merit Medical Completes Acquisition
> Rocky Mountain Companies Q3 Venture Capital Totals Around $340M
> Medical Imaging Holdings Buys Sonora Medical Systems

---

Techrockies.com Home